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EXAMINATION OF SOMATIC SYMPTOMATOLOGY USING THE CLEVELAND
ADAPTIVE PERSONALITY INVENTORY AND THE DIMENSIONAL SOMATIC
QUESTIONNAIRE
ELIZABETH KISELA
ABSTRACT
This study was designed to assess the reliability and validity of the Cleveland Adaptive
Personality Inventory (CAPI) and the Dimensional Somatic Questionnaire (DSQ) on the
chronic pain population, depression population, and healthy control population. A total of
178 chronic pain participants, 208 depression participants, and 220 healthy control
participants were collected, though not all were used for analysis due to missing data.
Each participant was administered an online version of the CAPI with the Dimensional
Somatic Questionnaire. Both questionnaires were significantly shortened during or prior
to analysis. The questionnaires were shortened to make them more practical for use in the
clinical setting. This study documented acceptable to excellent reliability for all 10 main
scales of the CAPI across all three groups. Additional findings for the CAPI showed that
the somatic scale and depression scale were highly sensitive and specific to the chronic
pain and depression populations, respectively. The DSQ demonstrated excellent overall
reliability. The DSQ was not found to be useful in distinguishing between chronic
somatic symptomatology and chronic emotional symptomatology and was not found to
have three constructs (e.g. mental health, emotional health, and behavioral health).
However, it was found sensitive and specific to chronic pain patients and would be useful
in deciphering the amount of functional impairment a chronic pain participant may have.
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CHAPTER I
INTRODUCTION

1.1 Background

A report written in 2011 by the Institute of Medicine, in collaboration with the
National Academy of Sciences, stated that the United States spends up to $635 billion
each year in medical treatment and lost productivity due to chronic pain. The quality of
life for people who suffer from chronic pain is greatly diminished and because of this,
chronic pain patients can develop psychological issues like depression or anxiety.
Chronic pain occurs in 33% of adult Americans (Johannes, Kim Le, Zhou, Johnston, &
Dworkin, 2010). To more efficiently diagnose and productively treat the 33% of
American adults as well as many other chronic pain patients around the world, a
personality assessment and somatic questionnaire are necessary to streamline the process.
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1.1.1 Somatic Manifestations and the Medical Community

It has been a long road for the outside world to believe that emotional problems
can manifest themselves into physical illnesses. Freud developed theories regarding
traumatic hysteria in the late 1800s, but due to the inability to replicate his work
scientifically, his work was falling on deaf ears in the medical community (Aron & Starr,
2013). What did emerge from Freud’s work was the recognition that irritability, mood
changes, and pain are often symptoms of a psychosomatic problem, not simply a medical
one. Even in the more recent medical community, studies have shown that anywhere
from 25% to 50% of patients seen by physicians have psychological disorders in addition
to medical problems (Asaad, 2000; Mostofsky & Barlow, 2000); and many of those
patients are left undiagnosed and not referred for treatment of those psychosocial
probelms (American Journal of Managed Care, 1999).
Freud eventually abandoned some of his theories regarding the cause of hysteria
and the American Psychological Association (APA) dropped hysteria from The
Diagnostic and Statistical Manual of Mental Disorders III (3rd ed.; DSM-III; American
Psychiatric Association, 1952) officially, stating that hysteria is too morally laden to be
considered a psychical condition (Libbrecht & Quackelbeen, 1995). The American
Medical Association also no longer use the term hysteria as a medical diagnosis, although
somatic manifestations were occurring without known etiology remains a common
phenomenon. Given these findings, Grobin (1960) stated that the medical community has
a difficult time accepting psychosomatic medicine as a true science and believing in the
fact that a person’s psyche is directly related to the development and treatment of their
2

physical illness. He went on to begrudgingly admit that psychosomatic medicine offers a
more comprehensive approach to the patient and the illness, but noted that questions
remain as to whether the medical community at that time should take psychosomatic
symptoms seriously.
More recently there have been numerous studies done that show a patient’s
mindset can influence the outcome of a surgical procedure and sometimes the cost and
overall perception of success of the surgical procedure (Ayers, Franklin, & Ring, 2013;
Fox et al., 2013; Sharma et al., 2016). More recent studies show that chronic pain,
somatization, and psychosomatic issues may be a result of central sensitization, a central
nervous system process causing hyperalgesia diffusely throughout the body (Woolf,
2011; Meeus & Nijs, 2007; Phillips & Clauw, 2011). Following the understanding that
mind and body symptoms are related, the medical community has become more
accepting of psychosomatic medicine. This is evidenced by the numerous
interdisciplinary pain rehabilitation programs available to patients who face somatic
disorders, which include the Cleveland Clinic Foundation and the Mayo Clinic. Further
evidence of the medical community’s acceptance are the relatively new requirements at
many facilities of psychological evaluations prior to major surgeries.

1.1.2 Gender and Chronic Pain

It is a widely held clinical opinion that females are more susceptible to pain and
exhibit more pain behaviors than their male counterparts (Lawlis, Achterberg, Kenner, &
3

Kopetz, 1984). Some pain modulation mechanisms and sex hormones could be
contributing factors to this opinion (Nahman-Averbuch, Sprecher, Brill, Yarnitsky, &
Jacob, 2016). There is even some research that suggests, in certain pain scenarios, the X
chromosome has a role in how much pain is expressed, which makes women more likely
to develop chronic, lasting pain (Linnstaedt, et al., 2015). No certain number of women
or men were put into this trial despite the evidence that women may be more prone to
exhibit pain and pain behaviors. A factor analysis of women and men separately was
intended to be done to determine if factor structure is similar for both men and women,
however, there was not enough men collected to perform a reliable analysis.

1.1.3 Psychosocial Issues Derived from Chronic Illnesses

Serious somatic symptoms, including chronic pain and fibromyalgia, cause a great
deal of anger, depression, fatigue, and anxiety in people who have experienced them
(Shuchang et al., 2011). Therefore, a great deal of research has been conducted to help
people who experience these negative feelings chronically. New methods for identifying
patients who are likely to develop chronic pain is therefore of great interest to both
researchers and clinicians. Mansour et al. (2013), for example, studied, using brain
imaging techniques, the white matter structural properties of pain patient and was able to
predict the amount of pain manifested by at least eighty percent of the outcomes.
Recent brain imaging studies show that there are new treatments for patients with
chronic pain. For example, Deogaonkar et al. (2016) used functional magnetic resonance
4

imaging (fMRI) to map areas of the brain that modulate pain. In that study, it was
demonstrated that the brain’s emotional networks, which process and facilitate emotional
connectivity, could be relieved for chronic pain patients through therapeutic spinal cord
stimulation. Although the study included only 10 patients, the results are informative and
another stride forward in the treatment for patients who suffer from chronic pain.
Studies like those that had been previously reviewed suggest that there is a
growing need for reliable and valid measures for the diagnoses of chronic pain patients.
A way to distinguish origin of chronic conditions can help current chronic pain patients
find their way to relief through cutting edge medical treatments as they progress coupled
with the best psychotherapy for their current psychosomatic stressors. Another reason
why new measures are necessary would be because of the high comorbidity rates of
depression and anxiety with chronic pain. Depression is the most frequent comorbid
mood disorder with chronic pain, with anxiety as a close second (Von Korff et al., 2005).

1.2 DSM-5, ICD-10, and CAPI with Dimensional Somatic Questionnaire

The Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5;
American Psychiatric Association, 2013), is the current diagnostic manual for mental
health professionals. It is a manual for the classification and diagnosis of mental disorders
and is updated periodically by the American Psychiatric Association (APA). The
International Statistical Classification of Diseases and Related Health Problems (10th
revision; ICD-10; World Health Organization, 1992) is a coding system that most
5

healthcare providers in the United States use to classify a patient’s diagnoses, symptoms,
procedures, and surgeries for use in billing and record-keeping for hospital care. It is a
periodically updated with new illness types, symptoms, and procedures by the World
Health Organization (WHO) and implemented throughout the United States’ medical
facilities. Every diagnosis in the DSM-5 is directly linked to an ICD-10 code.

1.3 Why is a New Somatic Scale Needed?

A reliable, valid personality assessment that is directly linked to DSM-5 criteria
for psychosomatic disorders and ICD-10 diagnosis codes for somatization disorders
would make diagnosing and treating somatically stricken patients with mental health
issues more efficient and more effective.

6

CHAPTER II
REVIEW OF EXISTING MEASURES

2.1 Physical Health Questionnaire-15

A popular and often-used scale in the health care setting for somatization is the
Physical Health Questionnaire-15 (PHQ-15) (Kroenke, Spitzer, & Williams, 2002) which
recently produced the abbreviated version called the Somatic Symptom Scale-8 (SSS-8)
(Gierk et al., 2013). The PHQ-15 is an assessment used to identify symptoms over the
last four weeks while the SSS-8 is used to identify symptoms over the past seven days.
Both measures have been empirically tested for validity and reliability and fare quite well
(Gierk et al., 2015).
The PHQ was developed as a small part of a Type A behavior pattern assessment
by Spence, Helmreich, and Pred (1987). Looking at physical health was not a focus for
their study; instead, the PHQ was developed to look at four dimensions of somatic health:
quality of sleep, digestion issues, headaches, and respiratory problems. When initially
created and studied, Spence et al. (1987) reported that all four subscales were
7

significantly intercorrelated (ranging from .17 to .43) and their internal consistency
reliabilities were above α = .75. The more recent overall index including only 14 items
was developed and used by Rogers and Kelloway (1997) and Schat and Kelloway (2000,
2003) in workplace aggression and violence studies. The original PHQ included 32 items,
while the revised and more recently utilized PHQ was minimized to a 14-item scale using
only three dimensions, excluding the respiratory problems dimension. Once that scale
was developed, an overall index of somatic health based questionnaire was created on all
items. Both scales, subscale and overall index, showed reliabilities above α = .80 in
separate studies (Rogers & Kelloway, 1997; Schat & Kelloway, 2000; Schat & Kelloway,
2003). In a study done by Schat, Kelloway, and Desmarais (2005), despite having
narrowed down the dimensions to three and being reliable in measuring an overall
somatic symptomatology index, the PHQ was found to be a psychometrically sound
instrument that measures four dimensions: gastrointestinal problems, headaches, sleep
disturbances, and respiratory illness. This outcome is very similar to the original, but it
has only half of the questions, making it very usable for current clinicians.

2.2 Somatic Symptom Scale-8

The SSS-8 is an even shorter version of the PHQ-15. It has good internal
consistency (α = .81) and it also measures four dimensions: gastrointestinal issues, pain,
fatigue, and cardiopulmonary somatic aspects. The SSS-8 was significantly associated
with depression, anxiety, health status, and use of the health care system by a self-report
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survey in Germany using a random-route sampling procedure and doing analysis on
2,510 participants’ responses (Gierk et al., 2013). When studied by Gierk et al. (2014),
the abbreviated version of PHQ-15, was found to identify individuals with low, medium,
high, and very high somatic symptom burden. The SSS-8 was also found to have a higher
correlation between somatic symptom burden to depression and anxiety than to general
health status. This finding could suggest that somatic symptoms and mental health have a
comorbid relationship. While the SSS-8 shows that this relationship exists, the CAPI and
Dimensional Somatic Questionnaire can expand on that relationship to see if it is strong
enough for diagnosis.
The PHQ-15 and the SSS-8 do measure symptoms but they do not measure a
patient’s personality and combine those results in making a tentative diagnosis as the
somatic scales on the CAPI will hopefully accomplish. The PHQ-15 and SSS-8 are
primary used in order to determine symptomatology for a physical ailment and make no
attempt in correlating their results to any mental health criteria. The Dimensional Somatic
Questionnaire in congruence with the CAPI will allow for mental health professionals
and physicians to get a better understanding of how these somatic symptoms are affecting
their patients’ thought processes in a mental health capacity.

2.3 Minnesota Multiphasic Personality Inventory (MMPI)

The MMPI is one of the most widely used personality assessment commercially
available (Butcher & Perry, 2008; Kleinmuntz, 1967; Lanyon & Goodstein, 1982), which
9

is why there has been an ample amount of research conducted on the MMPI (Butcher &
Perry, 2008; Lanyon & Goodstein, 1982). It is used in a variety of settings, including: the
military, employment settings, police officers, and clinical inpatient and outpatient
settings.

2.3.1 MMPI Hypochondriasis Scale

The Hypochondriasis scale of the MMPI and subsequent editions of the MMPI is
a scale that was developed to identify patients displaying a pattern of symptoms
associated with health and illness anxiety (Graham, 1990). A number of different
constructs labeled poor physical health, digestive difficulties, bad eyesight, lung damage,
poor bowel function, hypochondriasis, sinusitis, and hospitalization deal specifically with
somatic concerns and can be conceptualized into a simple, unidimensional scale:
hypochondriasis.
When a person scores extremely high (T>80) on this scale on the MMPI, bizarre
and exaggerated somatic complaints are likely occurring. This scale can be coupled with
other scales, which have yet to be developed in the CAPI, to develop more complex
diagnoses for an individual. Scores in the high mid-range (T=60-80) typically identify
patients with stomach issues. Patients who have true physical problems generally do not
exceed T≤60. If a patient with a true physical problem scores higher than a 60, a
psychological issue should be strongly considered.
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As the MMPI is a personality assessment, personality traits can be discerned for
patients who score at certain levels on this test. High scorers on the hypochondriasis scale
(T>60) are likely narcissistic and self-involved with a negative, pessimistic outlook on
life. This type of person generally feel miserable and dissatisfied and makes life for their
caregivers, family, and friends difficult by being demanding, critical, and indirectly
hostile toward them. With these high scorers, their pain is more likely to be longstanding
and the person may have minimal healthy coping mechanisms for their pain. Moderately
high and high scorers tend to lack insight to the actual psychological causes or aspects of
their physical presentation and have a hard time accepting psychological interpretation,
this makes treatment methods more difficult. Because this scale is unidimensional, low
scorers are typically the opposite of high scorers and are more accepting of treatment
(Graham, 1990).
The MMPI-2 was used in a chronic pain research project and expanded on the
MMPI hypochondriasis scale. Some questions were deleted and some modified for a
multitude of reasons for the MMPI-2, so re-standardizing and confirming validity and
reliability in the chronic pain subgroup was necessary. The analysis used a sample of
chronic pain patients in the Minnesota and Midwestern region. The control group,
however, was not a group in the Midwestern region and was not a medical population,
which would have been the ideal control population for re-standardization of the MMPI-2
(Keller & Butcher, 1991). The population that the CAPI will be using as a control will be
in the medical community, but will not be suffering from chronic pain symptoms. The
CAPI with the Dimensional Somatic Questionnaire will likely offer similar outcomes to
the MMPI with fewer questions, ease of taking it online for free, and will continually be
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developed further by the top minds in the chronic pain world to make for the best
coverage of all the possible symptoms involved. Creating the CAPI and the Dimensional
Somatic Questionnaire is an endeavor to create more reliable and valid data than the
MMPI Hypochondriasis scale provides, which will allow for an implementation of a
treatment regimen and diagnosis that can be counted on by the treating physician and/or
psychologist.

2.4 The Cleveland Adaptive Personality Inventory (CAPI)

The CAPI (Poreh, 2007) was in development for over a decade. The purpose of
this new measure is to apply adaptive methodology, much like the one proposed by
Butcher (2000) toward the study of personality functioning. While the Minnesota
Multiphasic Personality Inventory (MMPI), the Millon Clinical Multiaxial Inventory
(MCMI), and the Personality Assessment Inventory (PAI) are expensive, and too lengthy
for use in many medical settings, the CAPI is shorter, after the most recent revision, free
upon request, and geared toward the ICD-10. The expense of existing multidimensional
measures is a barrier because several somatoform disorders have their highest incidence
in the lower socioeconomic status patient population (American Psychiatric Association,
2013), and these patients are unlikely to be able to afford the expense of the test.
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2.5 Development of the Dimensional Somatic Questionnaire

There are many somatization scales being utilized by medical professionals today
(Zijlema et al., 2013). The scales used today and the somatization scales used in the past
ask a variety of questions that can be clustered into a number of constructs such as
gastrointestinal issues, fatigue, cardiopulmonary issues, bodily preoccupation,
hypochondriasis, disease phobia, and concerns about pain. These constructs were used to
develop a symptom profile with little incorporation of mental health diagnosis. The CAPI
and Dimensional Somatic Questionnaire aims to get an understanding of the 3 broader
constructs: mental health, behavioral health, and emotional health of the patient
presenting with somatic complaints. By using the three broad constructs (mental,
behavioral, and emotional health) and a lie scale, the patient will be able to convey their
specific mental disorder, if one is present. The focus of the Dimensional Somatic
Questionnaire is to not only develop the symptom profile of the patient, much like the
numerous other somatic scales in use today, but to also give insight to how severe the
patient’s mental health problems may be. This will give the practitioner a clearer view of
how to diagnose and treat the individual during and after their assessment.

13

CHAPTER III
METHOD

3.1 Participants

The chronic pain participants included in this research experiment were subjects
enrolled in ResearchMatch.org who had self-reported a diagnosis of chronic pain,
fibromyalgia, or any other serious somatic symptom disorder. The control sample of this
research experiment included subjects enrolled in ResearchMatch.org who had not selfreported a diagnosis of chronic pain, fibromyalgia, or any other serious somatic symptom
disorder causing pain. The depression sample of this research experiment included
subjects enrolled in ResearchMatch.org who had self-reported a current or past diagnosis
of any kind of depression.

14

3.2 Procedure

In the initial stage of development of the somatic scales for the CAPI items were
generated per the DSM-5 and ICD-10 criteria of each somatic disorder in the somatic
symptoms and related disorders chapter. All the items are measured on a 4-point Likert
scale (true, mostly true, mostly false, and false). Items have been adopted and modified
from previously published measures. The final item pool includes 330 questions for the
CAPI and an additional 56 questions for the Dimensional Somatic Questionnaire.
Participants contacted through ResearchMatch.org were contacted only if they
had self-disclosed a diagnosis of fibromyalgia or chronic pain. The control participants
contacted through ResearchMatch.org were contacted if they had not disclosed any
psychological disorder, chronic pain, or fibromyalgia diagnoses. Another group of
participants, who have disclosed a diagnosis of depression, were included to establish if
somatic pain disorders can be distinguished from emotional pain disorders, like
depression.
Once participants were deemed eligible, they were invited through
Researchmatch.org to participate in the CAPI and the Dimensional Somatic
Questionnaire. If accepted, they consented and demographic questions were asked,
including: age, gender, level of education, list of all current medical conditions, list of all
medications the participant is currently taking, and to identify how the developed chronic
pain (if they had chronic pain). All participants were administered the CAPI with the
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Dimensional Somatic Questionnaire. It is estimated that it took 60-120 minutes to
complete both the CAPI and the DSQ.
A total of 178 participants were collected for the chronic pain group, 208
participants were collected for the depression group, and 220 healthy control participants
were collected. After removing all participants who had more than 10 missing answers, a
total of 134 were in the chronic pain group, 137 in the depression group, and 151 in the
healthy control group for the CAPI questionnaire. An additional 1 participant was
removed in the depression group and 2 participants were removed in the healthy control
group for the DSQ analysis due to 5 or more missing answers on the DSQ. The chronic
pain group did not have any participants removed for the DSQ analysis. The DSQ had a
repeat question, numbers 18 and 55, so question 55 was removed prior to analysis.
Reliability was measured using Cronbach α for the CAPI and DSQ. Validity was
measured by ROC curve for both questionnaires. A factor analysis for the DSQ and a
one-way ANOVA for the CAPI were used to measure validity as well. Mean T-score
profiles for the CAPI were established for healthy participants, chronic pain participants,
and depressed participants.

16

CHAPTER IV
RESULTS AND DISCUSSION

4.1 CAPI Reliability and Validity

The full-version CAPI was given to each participant (330 questions), but during
the process of this research, the CAPI was shortened to 173 questions. The questions
were removed to make the personality inventory more practical in the clinical setting.
All questions have remained the same during the process of shortening the CAPI, so the
reliability and validity of only the newer, shorter version of the CAPI will be discussed.
The CAPI has an excellent overall reliability (Cronbach α = .90). Tables I-IV
show the reliability of the various scale across the three groups (chronic pain, depression,
and healthy controls) as well as the overall reliability of the various scales for all groups
combined. One sees that the reliability ranges from α = .69-.91 in the chronic pain group,
α = .68-.92 in the depressed group, α = .72-.92 in the healthy control group, and α = .71.94 across all groups.
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A one-way analysis of variance (ANOVA) for each scale was calculated on each
of the three groups (chronic pain, healthy controls, and depressed participants) to
determine if they significantly differ on all main scales of the CAPI. The analysis was
significant at p<.01 or less, to correct for Type I error, for all scales: SOM: F(2, 427) =
149.72, p<.001; DEP: F(2, 427) = 86.36, p<.001; AVO: F(2, 430) = 51.34, p<.001; SOC:
F(2, 427) = 8.51, p<.001; BOR: F(2, 427) = 66.28, p<.001; PAR: F(2, 427) = 31.64,
p<.001; ANX: F(2, 427) = 76.21, p<.001; SCHIZ: F(2, 427) = 19.44, p<.001; MAN: F(2,
427) = 21.92, p<.001; OCPD: F(2, 427) = 16.50, p<.001. It should be noted that the
Levene’s test of the homogeneity of variance was not satisfied for 3 of the main scales
(DEP: p=.005, BOR: p=.004, and PAR: p=.031), but was satisfied for the rest of the
scales at p>.14 or higher.
A post-hoc analysis (Tukey’s) was done to determine specific differences between
groups on the Somatization, Avoidant, Sociopathy, Anxiety, Schizotypy, and Mania
scales as they passed the Levene’s test of homogeneity of variance. Tukey’s post-hoc
analysis revealed that all three groups did significantly differ at p<.01, to correct for Type
I error, on each of the 10 main scales except for the following: The chronic pain group’s
mean score on the Sociopathy scale was higher than the control group but did not
significantly differ (p=.62). This suggests that the Sociopathy scale may not be able to
differ between the chronic pain group and the control group or that chronic pain and
healthy control subjects do not differ when it comes to sociopathy. The chronic pain
group and the depression group did not significantly differ on 4 of the main scales
including the Anxiety scale (p=.07), Mania scale (p=.33), OCPD (p=.06), and the
Schizotypy scale (p=.97). The chronic pain group’s mean score on the Anxiety, Mania,
18

and OCPD scales were lower than the depression group, but not significantly different.
The depression group’s mean score was lower, but not significantly different, on the
Schizotypy scales. This means that the CAPI does not differentiate these two patient
populations on these scales.

A post-hoc analysis (Games-Howell) was done to determine specific differences
between groups on the Depression, Borderline, and Paranoia scales as they did not pass
the Levene’s test of homogeneity of variance and Games-Howell is designed for unequal
variances and is based on the q-statistic distribution. This shows a significant difference
on all scales (p<.005) except for one. The depression group’s mean score on the
Depression scale was higher than the chronic pain group’s mean score, but was not
significantly different (p=.12). This means that the two groups are not able to be
differentiated on another of the main scales (Depression), though the depression group
did score higher, which is what the scale is intended to do.

The area under the curve (AUC) on the Depression scale for the depression group
and on the Somatic scale for the chronic pain group are Figure 1 and Figure 2,
respectively. The AUC measures sensitivity and specificity; how often the scale
accurately predicts depression and somatization on depressed and chronic pain patients,
respectively, and how often they don’t have depression and somatization when they do
not. The area under the curve for the Depression scale for the Depressed group is .72,
which would be considered fair. The area under the Somatic scale for the Chronic Pain
group is .83, which would be considered good.

19

Table I – CAPI Reliability for Chronic Pain group
Scale

Cronbach Alpha

Mean

SD

Somatization (SOM)

Number of
items
15

.793

39.40

7.57

Depression (DEP)

15

.914

36.46

9.96

Avoidant (AVO)

15

.874

37.25

8.60

Borderline (BOR)

15

.869

28.02

8.26

Sociopathy (SOC)

19

.713

41.41

7.30

Paranoia (PAR)

15

.897

29.26

8.64

Anxiety (ANX)

15

.905

38.18

9.63

Schizotypy (SCHIZ)

15

.799

24.39

6.74

Mania/Bipolar (BI)

15

.801

29.87

7.22

OCPD (OCPD)

10

.693

20.93

4.91
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Table II – CAPI Reliability for Depressed group
Scale

Cronbach Alpha

Mean

SD

Somatization (SOM)

Number of
items
15

.828

33.23

8.10

Depression (DEP)

15

.915

38.70

10.10

Avoidant (AVO)

15

.849

41.81

7.80

Borderline (BOR)

15

.848

32.12

8.18

Sociopathy (SOC)

19

.753

38.54

7.70

Paranoia (PAR)

15

.896

32.70

8.90

Anxiety (ANX)

15

.880

40.68

8.61

Schizotypy (SCHIZ)

15

.835

24.20

6.98

Mania/Bipolar (BI)

15

.796

31.10

6.99

OCPD (OCPD)

10

.678

22.31

4.89
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Table III – CAPI Reliability for Healthy Control group
Scale

Cronbach Alpha

Mean

SD

Somatization (SOM)

Number of
items
15

.819

24.40

6.90

Depression (DEP)

15

.920

25.20

8.60

Avoidant (AVO)

15

.890

31.83

8.40

Borderline (BOR)

15

.872

22.02

6.37

Sociopathy (SOC)

19

.733

37.07

7.00

Paranoia (PAR)

15

.888

25.04

7.38

Anxiety (ANX)

15

.923

28.29

9.26

Schizotypy (SCHIZ)

15

.838

20.23

5.87

Mania/Bipolar (BI)

15

.841

25.89

7.14

OCPD (OCPD)

10

.724

19.04

4.91
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Table IV – CAPI Reliability across all 3 groups
Scale

Cronbach Alpha

Mean

SD

Somatization (SOM)

Number of
items
15

.881

31.90

9.80

Depression (DEP)

15

.938

33.05

11.30

Avoidant (AVO)

15

.896

36.69

9.24

Borderline (BOR)

15

.890

27.12

8.67

Sociopathy (SOC)

19

.743

38.91

7.54

Paranoia (PAR)

15

.906

28.80

8.86

Anxiety (ANX)

15

.928

35.34

10.67

Schizotypy (SCHIZ)

15

.835

22.80

6.79

Mania/Bipolar (BI)

15

.822

28.80

7.46

OCPD (OCPD)

10

.711

20.68

5.08
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Area Under the Curve
Test Result Variable(s): DEP
Area
.722
The test result variable(s): DEP has at least one tie
between the positive actual state group and the
negative actual state group. Statistics may be biased.

Figure 1. Measure of specificity and sensitivity of the Depression scale for the depressed
participants.
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Area Under the Curve
Test Result Variable(s): SOM
Area
.828

The test result variable(s): SOM has at least one tie
between the positive actual state group and the
negative actual state group. Statistics may be biased.

Figure 2. Measure of specificity and sensitivity of the Somatic scale for the chronic pain
participants.
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Figures 3-6 show the T-score profiles on each of the 10 main scales and the
Naiveté scale for chronic pain participants (Figure 4), depressed participants (Figure 5),
healthy controls (Figure 6), and all three overlapping (Figure 3).

Overlapping Profiles
60.00
58.00

Average Score

56.00
54.00
52.00
50.00
48.00
46.00
44.00
42.00
40.00

SOM

DEP

AVO

SOC

BOR

PAR

ANX

SCIZ

BI

OCPD

N

Series1

57.82

52.97

50.50

49.27

51.04

50.51

52.66

52.34

51.43

50.51

51.21

Series2

51.12

55.09

55.49

52.79

55.76

54.40

55.00

52.06

53.09

53.21

47.94

Series3

42.35

43.05

44.91

48.21

44.12

45.75

43.39

46.22

46.10

46.79

50.74

Figure 3. Overlapping CAPI profiles with chronic pain participants in blue, depression
participants in orange, and healthy control participants in gray.

26

Chronic Pain Profile
60.00

55.00

50.00

45.00

40.00
SOM

DEP

AVO

SOC

BOR

PAR

ANX

SCIZ

BI

OCPD

N

Figure 4. Chronic Pain participant profile for the 10 main CAPI scales and the Naiveté
scale.
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Depressed Profile
60.00

55.00

50.00

45.00

40.00
SOM

DEP

AVO

SOC

BOR

PAR

ANX

SCIZ

BI

OCPD

Figure 5. Depressed participant profile for the 10 main CAPI scales and the Naiveté
scale.
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N

Healthy Control Profile
60.00

55.00

50.00

45.00

40.00
SOM

DEP

AVO

SOC

BOR

PAR

ANX

SCIZ

BI

OCPD

N

Figure 6. Healthy control participant profile for the 10 main CAPI scales and the Naiveté
scale.
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4.2 DSQ Reliability and Validity

Prior to the removal of questions, the DSQ had excellent reliability (Cronbach α =
.92). For the 56-question DSQ, the Bartlett’s test of sphericity was significant (χ2 (395) =
4327.39, p<.001). The Kaiser-Meyer Olkin measure of sampling adequacy was .93, well
above the commonly recommended value of .60. However, the MSA values on the antiimage matrix were .65 or above and some partial correlation values were above .8. This
indicates that some questions needed to be removed due to multicollinearity prior to
completing a factor analysis.
A total of 36 questions were removed due to multicollinearity and to shorten the
questionnaire to make it more feasible for use in the clinical field. After the removal of
36 questions the DSQ had even better overall reliability (Cronbach α = .95). The resulting
DSQ was 20 questions in length, the Bartlett’s test of sphericity was still significant (χ2
(395) = 4633.40, p<.001) and the Kaiser-Meyer Olkin measure of sampling adequacy
was improved to .96. The MSA values on the anti-image matrix were all above .90, and
the partial correlation values were .70 or below, further confirming that each item shared
some common variance with other items. Therefore, factor analysis was deemed suitable
after the removal of highly multicollinear questions.
The factor analysis used a principal component extraction method with a varimax
rotation. There were three possible factors, but after examining the eigenvalues and
removing all factors below a value of 2 that did not account for at least 6% of the
variance there was only one factor. The primary factor accounted for 50.05% of the
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variance in individual’s responses. Upon examining the scree plot, the eigenvalue
analysis that defined only one factor exists was supported.
The area under the curve for each of the three possible factors and the full, 56question DSQ is shown in Figure 7. The area under the Somatic Scale Final (56-question
DSQ) curve is 0.80, which would be considered fair. The AUC for the Somatic Scale 20
Item (20-question DSQ) is 0.85, which improved to good after the removal of 36
questions. The 20-question DSQ improved on all the factors’ area under the curve and
improved on the 56-question DSQ, which means the shortened DSQ is the most effective
at discriminating between chronic pain participants and healthy participants (Figure 8).
A one-way analysis of variance (ANOVA) was calculated on each of the three
groups (chronic pain, healthy controls, and depressed participants) to determine if they
significantly differ on the DSQ. The analysis shows that they do significantly differ on
the DSQ F(2, 392) = 156.87, p<.001. Post-hoc analysis (LSD and Tukey’s) showed a
significant difference between all groups (p<.001).
An analysis between women and men was not performed due to lack of male
participants.

31

Area Under the Curve
Test Result Variable(s)

Area

Somatic_Scale_Final

.799

REGR factor score 1 for analysis 2

.791

REGR factor score 2 for analysis 2

.601

REGR factor score 3 for analysis 2

.748

The test result variable(s): Somatic_Scale_Final has at least
one tie between the positive actual state group and the
negative actual state group. Statistics may be biased.

Figure 7. Measure of specificity and sensitivity of the 56-item DSQ and the possible
factors for all participants.
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Area Under the Curve
Test Result Variable(s)

Area

Somatic_Scale_20_item

.850

REGR factor score 1 for analysis 2

.789

REGR factor score 2 for analysis 2

.600

REGR factor score 3 for analysis 2

.749

The test result variable(s): Somatic_Scale_20_item has at
least one tie between the positive actual state group and the
negative actual state group. Statistics may be biased.

Figure 8. Measure of specificity and sensitivity of the 20-item DSQ and the possible
factors for all participants.
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4.3 Discussion

The current study was an attempt to examine the reliability and validity of the
CAPI among the chronic pain and depression populations. It was also an attempt to
examine the reliability, validity, and specificity of the DSQ among chronic pain and
depressed populations. Both questionnaires were shortened from their original form prior
to or during analysis for practical use in a clinical setting and for increased reliability and
validity purposes.
As noted above, the CAPI was a very reliable and valid questionnaire for all three
groups of participants (healthy, chronic pain, and depressed). The one-way ANOVAs on
each of the scales showed that the chronic pain group and depression group did not
significantly differ on 5 of the main scales. This is not surprising as chronic pain patients
often suffer from depression and anxiety, (Fishbain, Cutler, Rosomoff, & Rosomoff,
1997; Poole, White, Blake, Murphy, & Bramwell, 2009; Sullivan, Reesor, Mikail, &
Fisher, 1992; Worz, 2003) making differentiating between these two groups very
difficult. It was found that the depressed group scored higher, though not significantly
higher the Depression, Anxiety, Mania, and OCPD scales, which could mean that these
scales are close to being able to differentiate the chronic pain population despite the
comorbidity rates, but are not quite adequate yet. Further work will need to be done on
these scales to properly differentiate between the two groups on the Depression, Anxiety,
Mania, OCPD, and Schizotypy scales.
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Chronbach’s α showed acceptable (α=.711) to excellent (α=.938) across all three
groups on each scale. There were only two reliabilities lower than acceptable for each
group on every scale. These were on the OCPD scale in the depression population
(α=.68) and the chronic pain population (α=.69), which is considered questionable
reliability. Overall, the CAPI is a highly reliable questionnaire.
The area under the curve (AUC), measuring specificity and sensitivity, for the
depression population on the depression scale was fair. This indicates that the depression
scale can accurately predict depression when the subject does have depression
(sensitivity) and accurately identify patients as not having depression when they do not
(specificity) within the depressed population, even when depression is highly comorbid
with chronic pain. The AUC for the chronic pain population on the somatic scale was
good, indicating that the somatic scale is sensitive and specific when identifying the
chronic pain (including fibromyalgia) population. This shows that the depression and
somatic scales are both reliable and valid within their respective populations.
The DSQ was also a reliable and valid questionnaire, which was specific and
sensitive to chronic pain patients. Post-hoc analysis (Tukey’s and LSD) revealed that the
DSQ significantly differentiates between chronic pain, depressed, and healthy control
populations (p<.001). However, the factor analysis showed that there were not three
factors, as theorized, just one. This means it is unable to distinguish between emotional,
cognitive, and physical issues; therefore, it cannot help narrow down a diagnosis for
practitioners. The shortened, 20-item DSQ improved reliability, sensitivity, and
specificity from the longer DSQ, which makes it a very quick way for clinicians to assess
functioning in their chronic pain patients. The results showed that the 20-item DSQ
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would be best used as a measure of severity in overall functioning than as a
diagnostically relevant tool as it does not distinguish between emotional health,
behavioral health, and mental health as theorized.

4.3.1. Limitations of This Study

A significant limitation to this study is the fact that the DSQ was taken by 326
women and only 66 men and the CAPI was taken by 352 women and only 70 men.
Researchmatch.org metrics (2017) updates very regularly, but at the time of this
publication it shows of the over 113,000 volunteers, 70.8% are female, 28.9% are male,
and .3% are transgender. This makes the generalizability to the population very difficult
as the sample population was not equally distributed between sexes. Another limitation to
note is that researchmatch.org metrics (2017), shows that 76.4% of participants are white.
Though race was not collected in the experiment it could be assumed that the sample
population of races were not equally distributed, which limits generalizability to the
population.
Another possible limitation is the web-based means of collecting data. Hardré,
Crowson, Xie, and Ly (2007) found that web-based and computer-based administration
of questionnaires in research collected poorer quality data than paper-based in controlled
laboratory conditions. The poorer quality data may be attributed to computer anxiety in
certain populations (Schulenber & Yurtzenka, 1999), which could diminish over time as
all ages become more familiar and comfortable with computers. However, many studies
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have shown that web-based questionnaires are just as reliable and generalizable as a
paper-pencil questionnaire (Davis, 1999; Gosling, Vazire, Srivastava, & John, 2004). The
CAPI will be primarily a web-based personality questionnaire, but to have the best, most
reliable data for the validation of the CAPI and the DSQ, it may be best to have inperson, paper-pencil questionnaire data as well as web-based data.

4.3.2 Future Research

Further studies should be performed on male participants to ensure that the DSQ
and CAPI can discriminate between male chronic pain, depressed, and healthy
participants as this study had significantly fewer males compared to females. Though,
research does show that women suffer from chronic pain conditions, like fibromyalgia,
and depression at twice the prevalence of men (Munce & Stewart, 2007; Wolfe, Ross,
Anderson, & Russell, 1995; Yunus, 2001). Future studies should also collect race data to
ensure the data is generalizable to the population based on race.
Researchmatch.org is a self-report, volunteer-based website. This means that
many of the participants could have self-diagnosed themselves with chronic pain or
depression. This study should be repeated with a confirmed physician-diagnosed sample
of participants. This additional research would help ensure the profiles developed by Tscores in each of the 11 scales in this experiment for chronic pain patients, healthy
controls, and depressed patients are accurate. It would also confirm that the CAPI and
DSQ are reliable and valid measures with significant results.
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CHAPTER V
CONCLUSION

In summary, the present study provides further evidence that the CAPI is a
reliable and valid personality inventory that emphasizes modern diagnostic criteria with
minimal time required for practitioner and patient. The collaborative nature of the
inventory will improve the usefulness of such a personality inventory and increase the
usefulness in practice. The DSQ is also a reliable and valid chronic pain questionnaire
that can be useful in practice as a measure of functionality within the chronic pain
population, however, cannot identify what underlying issues the patient may be having
(e.g. mental health, emotional health, behavioral health). Future research should be done
to further the development of profiles for the CAPI, especially the OCPD scale, among
different patient populations.
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APPENDICIES
APPENDIX
DSM-5 criteria for Somatic Symptom and Related Disorders
SOMATIC SYMPTOM AND RELATED DISORDERS
Somatic Symptom Disorder
Key Criteria:
One or more somatic symptoms that are distressing or result in significant disruption of
daily life
Excessive thoughts, feelings, or behaviors related to the somatic symptoms
The state of being symptomatic is persistent, more than 6 months, whether somatic
symptoms are continuous or not
Illness Anxiety Disorder
Key Criteria:
Preoccupation with having or acquiring a serious illness
Somatic symptoms are not present or, if present, are only mild in intensity
There is a high level of anxiety about health
Health-related behaviors are performed excessively or exhibits maladaptive avoidance
behaviors
Illness preoccupation has been present for 6 months or more
Illness preoccupation cannot be explained by another disorder
Conversion Disorder
Key Criteria:
One or more symptoms of altered voluntary motor or sensory function
Clinical findings provide evidence of incompatibility between the symptom and
recognized neurological or medical conditions
Symptom is not better explained by another medical/mental disorder
Symptom causes clinical significant distress
Psychological Factors Affecting Other Medical Conditions
Key Criteria:
Medical symptom or condition (other than mental disorder) is present
Psychological or behavioral factors adversely affect the medical condition
The psychological and behavioral factors are not better explained by another mental
disorder
Factitious Disorder (Imposed on Self)
Key Criteria:
Falsification of physical or psychological signs or symptoms
Individual presents to others as ill, impaired, or injured
Deceptive behavior is evident even in the absence of obvious external rewards
Behavior is not better explained by another mental disorder
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APPENDIX
ICD-10 Criteria for Somatic Symptom and Other Related Disorders
F45.0 Somatization disorder

F45.1 Undifferentiated somatoform
disorder

F45.2 Hypochondriacal disorder

F45.3 Somatoform autonomic dysfunction
.30 Heart and cardiovascular system
.31 Upper gastrointestinal tract
.32 Lower gastrointestinal tract
.33 Respiratory system
.34 Genitourinary system

The main features are multiple, recurrent and
frequently changing physical symptoms of at
least two years duration. Most patients have
a long and complicated history of contact
with both primary and specialist medical care
services, during which many negative
investigations or fruitless exploratory
operations may have been carried out.
Symptoms may be referred to any part or
system of the body. The course of the
disorder is chronic and fluctuating, and is
often associated with disruption of social,
interpersonal, and family behavior. Shortlived (less than two years) and less striking
symptom patterns should be classified under
undifferentiated somatoform disorder
(F45.1).
When somatoform complaints are multiple,
varying and persistent, but the complete and
typical clinical picture of somatization
disorder is not fulfilled, the diagnosis of
undifferentiated somatoform disorder should
be considered.
The essential feature is a persistent
preoccupation with the possibility of having
one or more serious and progressive physical
disorders. Patients manifest persistent
somatic complaints or a persistent
preoccupation with their physical
appearance. Normal or commonplace
sensations and appearances are often
interpreted by patients as abnormal and
distressing, and attention is usually focused
upon only one or two organs or systems of
the body. Marked depression and anxiety are
often present, and may justify additional
diagnoses.
Symptoms are presented by the patient as if
they were due to a physical disorder of a
system or organ that is largely or completely
under autonomic innervation and control, i.e.
the cardiovascular, gastrointestinal,
respiratory and urogenital systems. The
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.38 Other organ or system

F45.4 Persistent somatoform pain disorder

F45.8 Other somatoform disorders

F45.9 Somatoform disorder, unspecified

symptoms are usually of two types, neither of
which indicates a physical disorder of the
organ or system concerned. First, there are
complaints based upon objective signs of
autonomic arousal, such as palpitations,
sweating, flushing, tremor, and expression of
fear and distress about the possibility of a
physical disorder. Second, there are
subjective complaints of a nonspecific or
changing nature such as fleeting aches and
pains, sensations of burning, heaviness,
tightness, and feelings of being bloated or
distended, which are referred by the patient
to a specific organ or system.
The predominant complaint is of persistent,
severe, and distressing pain, which cannot be
explained fully by a physiological process or a
physical disorder, and which occurs in
association with emotional conflict or
psychosocial problems that are sufficient to
allow the conclusion that they are the main
causative influences. The result is usually a
marked increase in support and attention,
either personal or medical. Pain presumed to
be of psychogenic origin occurring during the
course of depressive disorders or
schizophrenia should not be included here.
Any other disorders of sensation, function
and behavior, not due to physical disorders,
which are not mediated through the
autonomic nervous system, which are limited
to specific systems or parts of the body, and
which are closely associated in time with
stressful events or problems.
Psychosomatic disorder NOS
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APPENDIX
CONSENT FORM

Cleveland State University
Department of Psychology
2300 Chester Avenue, Room 158
Cleveland, OH 44115-2214
Consent Form
Study title: Cleveland Adaptive Personality Inventory (CAPI) with Additional Physical
Symptoms Questions
Sponsor: N/A
PI: Amir Poreh, PhD 216-704-1507
Student Study Coordinator (under observation of PI): Elizabeth Perry 740-605-4937
After hours phone contact #: 740-605-4937

Please note:




You are being asked to take part in a research study.
Ask as many questions as needed so you can make your choice.
You must be 18 years of age or older to take part.

1. ABOUT THE RESEARCH
Why is the study being done?
The study is to find out if the CAPI and the additional questions about your physical
symptoms will be a useful tool to help find mental disorders. Some people with physical
problems also have a mental disorder. If the CAPI helped find these people, it would help their
doctor chose the best treatment for them.
The CAPI has been given to college students, but has not yet been given to people with longlasting, long-term pain. We hope to learn more about why certain people develop this kind of pain
when others do not. You are being asked to join in this study because you have long-lasting, longterm pain or you do not have any long-lasting, long-term pain and will be a control.

What is involved if you decide to take part in this research study?
Taking part in the study includes finishing 330 questions on the CAPI and an
additional 56 questions about your physical health. Taking all 386 question should take
about 60-120 minutes. The questionnaire can be taken at any time after consenting
through the SurveyMonkey website link.
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2. RISKS
What are the risks of taking part in the research study?
There are no physical risks involved with this study. You can choose not to
answer any question if you wish. There is a small risk of loss of privacy. Every effort will
be made to keep your answers safe.
3. BENEFITS

What are benefits of taking part in the research study?
There are no direct benefits to you by taking part in this research.
4. COSTS & PAYMENT
Are there any costs or payments to you if you take part in this study?
There are no costs or payments to you for taking part in this study.
5. PRIVACY
What will happen to your information that is collected for this research?
Your answers to the questions will be kept private. The data will be kept on a secure
database. Your name will be changed to a number so your data will be safe. You will not be
identified in any way from this study or in any data files shared with other researchers.
You may decide not to allow use of your data at any time by getting in touch with the
Principal Investigator (PI) or student study coordinator, who is supervised by the PI, by using the
phone numbers or address listed at the top.
You will be given the questionnaire through SurveyMonkey.com’s secure site.
6. CONFLICT OF INTEREST
Do the researchers or institution have any conflicts of interest relating to this study?
There are no conflicts of interest to report.
7. QUESTIONS
Who do you call if you have any questions or problems?
If you have any questions or problems, please contact Amir Poreh, PhD at 216-704-1597.
After business hours, call 740-605-4937 and ask for Elizabeth Perry, the student study
coordinator.
8. TAKING PART IS OPTIONAL
What are your rights?
Taking part in this study is completely up to you. You may choose not to take part or may
leave the study at any time with no penalty.

9. SIGNATURES
Please read the following: “I understand that if I have any questions about my rights as a research
subject, I can contact the Cleveland State University Institutional Review Board at (216) 6873630.”
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After signing this form, please print one copy for your records.

Your electronic signature below on SurveyMonkey.com means that you understand the contents of
this document. You also are at least 18 years of age. Finally, you voluntarily consent to participate
in this research study.

_____________________________
Printed name of person obtaining consent

_____________________________

___________

Signature of person obtaining consent

Date
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